echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Researchers report the reliability of Pfizer's new crown vaccine trial data, and the effectiveness of FDA clinical supervision is questioned

    Researchers report the reliability of Pfizer's new crown vaccine trial data, and the effectiveness of FDA clinical supervision is questioned

    • Last Update: 2021-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    An investigative article published in the British Medical Journal (BMJ) on November 2, 2021 [1] received much attention.


    The information in the article comes from a disclosure by a regional director of the research organization Ventavia Research Group


    Poor laboratory management

    Poor laboratory management

    Ventavia states on its website that it is the largest private clinical research company in Texas


    Fear of FDA inspections

    Fear of FDA inspections

    During the meeting in late September, Jackson and Ventavia executives discussed the possibility of FDA inspections several times


    Complaint letter to FDA

    Complaint letter to FDA

    Jackson wrote in an email to the FDA on September 25 that Ventavia has recruited more than 1,000 participants in three venues


    Participant was left in the corridor after receiving the injection, without clinical staff monitoring

    Lack of timely follow-up of patients with adverse events

    Scheme deviation not reported

    The vaccine is not stored at the proper temperature

    The laboratory samples are mislabeled, and

    These types of issues have been reported to Ventavia employees

    A few hours later, Jackson received an e-mail from the FDA, thanking her for her concern, and notifying her that the FDA was unable to comment on the possible investigation


    Evidence from other employees

    Evidence from other employees

    In recent months, Jackson has reconnected with several former Ventavia employees


    [1] Thacker P D.


    [1] Thacker P D.
    Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial BMJ 2021; 375 :n2635 doi:10.
    1136/bmj.
    n2635
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.